Literature DB >> 21861591

A potential tool for the diagnosis of ALS based on diffusion tensor imaging.

Dafna Ben Bashat1, Moran Artzi, Ricardo Tarrasch, Beatrice Nefussy, Vivian E Drory, Orna Aizenstein.   

Abstract

Our objective was to quantify and better understand white matter (WM) impairment in patients with amyotrophic lateral sclerosis (ALS) and to propose a model based on diffusion tensor imaging (DTI) for diagnosing patients with suspected ALS with upper motor neuron (UMN) signs. Twenty-six ALS patients (24 with prominent UMN signs and two with an isolated lower-motor neuron (LMN) syndrome) and 22 healthy volunteers were examined using DTI. Data analysis included voxel-based WM tract-based spatial statistics (TBSS), volume-of-interest analysis of the TBSS results and stream-line tractography analysis. Converging evidence revealed WM impairment along the corticospinal tracts and in the mid-body of the corpus callosum. This was demonstrated by reduced fractional anisotropy values caused by increased radial diffusivity, without significant changes in axial diffusivity. There were no significant correlations between diffusivity indices and patients' disability or disease duration. A discriminant analysis model based on the tractography results was designed to distinguish between patients with UMN signs and controls, yielding 87.5% sensitivity and 85% specificity. In conclusion, DTI can detect WM impairment in patients with ALS in several brain regions, and might be a sensitive tool for the diagnosis of ALS in the early stages of the disease with UMN involvement.

Entities:  

Mesh:

Year:  2011        PMID: 21861591     DOI: 10.3109/17482968.2011.582646

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  9 in total

1.  Whole brain fiber-based comparison (FBC)-A tool for diffusion tensor imaging-based cohort studies.

Authors:  Gali Zimmerman-Moreno; Dafna Ben Bashat; Moran Artzi; Beatrice Nefussy; Vivian Drory; Orna Aizenstein; Hayit Greenspan
Journal:  Hum Brain Mapp       Date:  2015-10-31       Impact factor: 5.038

Review 2.  25 years of neuroimaging in amyotrophic lateral sclerosis.

Authors:  Bradley R Foerster; Robert C Welsh; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

3.  Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

4.  Injury of the arcuate fasciculus in a patient with progressive bulbar palsy.

Authors:  Min Cheol Chang; Han Do Lee; Sung Ho Jang
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

5.  Multimodal structural MRI in the diagnosis of motor neuron diseases.

Authors:  Pilar M Ferraro; Federica Agosta; Nilo Riva; Massimiliano Copetti; Edoardo Gioele Spinelli; Yuri Falzone; Gianni Sorarù; Giancarlo Comi; Adriano Chiò; Massimo Filippi
Journal:  Neuroimage Clin       Date:  2017-08-02       Impact factor: 4.881

6.  Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns.

Authors:  Peter Bede; Parameswaran M Iyer; Eoin Finegan; Taha Omer; Orla Hardiman
Journal:  Neuroimage Clin       Date:  2017-06-09       Impact factor: 4.881

7.  Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  BMC Neurol       Date:  2017-04-17       Impact factor: 2.474

Review 8.  Lessons of ALS imaging: Pitfalls and future directions - A critical review.

Authors:  Peter Bede; Orla Hardiman
Journal:  Neuroimage Clin       Date:  2014-02-27       Impact factor: 4.881

9.  Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model.

Authors:  Robert Steinbach; Nayana Gaur; Annekathrin Roediger; Thomas E Mayer; Otto W Witte; Tino Prell; Julian Grosskreutz
Journal:  Hum Brain Mapp       Date:  2020-10-26       Impact factor: 5.038

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.